UK markets closed

NIKKEI 225
38,460.08
+907.92(+2.42%)
HANG SENG
17,201.27
+372.34(+2.21%)
CRUDE OIL
82.91
-0.45(-0.54%)
GOLD FUTURES
2,332.20
-9.90(-0.42%)
DOW
38,498.89
-4.80(-0.01%)
Bitcoin GBP
51,585.57
-1,754.32(-3.29%)

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

39.22

+0.25

(+0.64%)

As of 03:55PM EDT. Market open.

Trade prices are not sourced from all markets

All

Zacks
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PR Newswire
Halozyme to Report First Quarter 2024 Financial and Operating Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its first quarter 2024 financial and operating results on Tuesday, May 7, 2024, following the close of trading.